The FDA's Center for Drug Evaluation and Research (CDER) is looking for five drug companies to participate in a Fit for Use pilot program to test the processing and analysis of nonclinical study data provided electronically for the Clinical Data Interchange Standards Consortium (CDISC) using the SEND 3.1 format.